PULMONX CORP (LUNG) Stock Cash Flow
NASDAQ:LUNG - Nasdaq - US7458481014 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -57.09M | -56.39M | -60.84M | -58.92M | -48.66M | |||
| Depreciation Amortization | 1.35M | 1.49M | 1.55M | 1.51M | 870.00K | |||
| Change In Working Capital | -1.86M | -1.70M | -2.56M | -7.01M | -7.85M | |||
| Interest Paid | 3.40M | 3.48M | 2.98M | 850.00K | 720.00K | |||
| Taxes Paid | 495.00K | 556.00K | 471.00K | 400.00K | 320.00K | |||
| Other non cash items | 24.64M | 25.07M | 24.24M | 19.34M | 14.25M | |||
| OPERATING CASH FLOW | -32.96M | -31.54M | -37.61M | -45.08M | -41.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.30M | -1.45M | -807.00K | -1.32M | -3.67M | |||
| Other Investing Activity | 37.59M | 18.92M | -1.20M | -2.91M | -42.58M | |||
| INVESTING CASH FLOW | 36.30M | 17.48M | -2.01M | -4.23M | -46.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -95.00K | 19.91M | -90.00K | 0.00 | |||
| Stock Issued/Repurchased | 1.26M | 1.46M | 1.49M | 2.56M | 4.50M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -50.00K | -40.00K | |||
| FINANCING CASH FLOW | 1.16M | 1.36M | 21.40M | 2.42M | 4.46M | |||
| Exchange Rate Effect | -77.00K | 76.00K | 34.00K | 150.00K | 110.00K | |||
| CHANGE IN CASH | 4.42M | -12.62M | -18.18M | -46.74M | -83.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -32.96M | -31.54M | -37.61M | -45.08M | -41.39M | |||
| Capital Expenditure | -1.30M | -1.45M | -807.00K | -1.32M | -3.67M | |||
| FREE CASH FLOW | -34.26M | -32.98M | -38.42M | -46.40M | -45.06M | |||
All data in USD